NewsAI-assisted

Sanofi to Invest €400 Million in Hyderabad Capacity Centre Expansion

Sanofi to invest €400M in Hyderabad, India, expanding its global capacity centre to 2,600 employees.

Mrudula Kulkarni
By Mrudula Kulkarni
Managing Editor - Pharma Now
Jul 18, 2024Updated Jun 26, 2025 · 2 min read
Sanofi to Invest €400 Million in Hyderabad Capacity Centre Expansion
https://seekingalpha.com/news/3929693-sanofi-to-lay-off-employees-at-2-vaccine-plans-in-india
AI-assisted reporting
Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

With a multi-year investment reaching 400 million euros ($437 million), Sanofi is reportedly planning to increase the number of employees at its global capacity centre in Hyderabad, India.

According to The Hindu, the investment will last until the end of the decade, with the first installment of 100 million euros ($109 million) arriving by the next year.

There are presently about 1,000 workers at the site, according to reports. According to The Deccan Herald, Madeleine Roach, executive vice president of business operations at Sanofi, stated during a press conference that the facility has the potential to grow to 2,600 employees over the course of the next two years, making it the largest of the company's four global capacity centres.

Bogota, Columbia; Hyderabad; Kuala Lumpur, Malaysia; Budapest, Hungary are the locations of the company's four global capacity centres. Chief digital officer Emmanuel Frenehard stated that the corporation is "resetting the footprint" and stepping up its "value accretive activities" in India, as reported by the Financial Express. The expansion will make use of artificial intelligence techniques and enlarge the site's digital crew.

TopicsNews
Mrudula Kulkarni
Written by
Mrudula Kulkarni
Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Loading discussion…

More from Pharma News

All stories →